Jasper Therapeutics, Inc. Common Stock
Symbol: JSPR (NASDAQ)
2.49
▼ (-3.71%) -0.096
Company Description:
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Key Stats
- Today's Open: $2.45
- Today's High: $2.62
- Today's Low: $2.245
- Today's Volume: 1.49M
- Yesterday Close: $2.59
- Yesterday High: $2.605
- Yesterday Low: $2.36
- Yesterday Volume: 353.42K
- Last Min Volume: 0
- Last Min High: $2.494
- Last Min Low: $2.494
- Last Min VWAP: $0
Company Profile
- Name: Jasper Therapeutics, Inc. Common Stock
- Website: https://www.jaspertherapeutics.com
- Listed Date: 2021-09-27
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001788028
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $40.63M
- Round Lot: 100
- Outstanding Shares: 16.25M
- Asset Type: CS
RECENT FILINGS FOR JSPR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-19 | 8-K | View |
| 2025-09-19 | 424B5 | View |
| 2025-09-18 | 424B5 | View |
| 2025-08-13 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-06 | SCHEDULE 13G | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-11 | SCHEDULE 13G | View |
| 2025-07-09 | 8-K | View |
| 2025-07-07 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-06-06 | 4 | View |
Latest News on JSPR